AVTECH: Clear path for continued growth
Research Update
2024-02-16
14:45
Analyst Q&A
Closed
Rasmus Jacobsson answered 9 questions.
Redeye states that the report aligned with preliminary figures and showed net sales in line with estimates, but EBITDA was slightly below Redeye’s expectations. The EBITDA ‘miss’ is related to ‘elevated’ OPEX, which we expect to remain as AVTECH plans on significant investments during 2024 to expand its product portfolio. Redeye sees short-term catalysts as it expects a few legacy carriers to conclude trials during Q1 2024. Redeye raised its fair value range.
RJ
ME
Rasmus Jacobsson
Mattias Ehrenborg
Contents
Estimates vs outcome
Several product launches are expected during 2024
Solid customer intake paves the way for sequential growth
Wizz Air
SAS – After quarter end
The pipeline is estimated to be worth SEK27m-43m
Lower EBITDA during the investment phase but higher longer-term
Trades below historic NTM EV/EBIT
Investment thesis
Quality Rating
Financials
Rating definitions
The team
Download article
The highs of the report were continued solid net sales growth, with net sales reaching SEK7.6m (0% deviation). Q4 2023 was the ninth quarter with double-digit net sales growth in a row. OPEX came in higher than expected due to higher personnel costs and fewer vacation days. Thus, EBITDA was 13% below our estimate, reaching SEK3.6m. We expect this ‘elevated’ OPEX level to be a new normal as AVTECH invests in the organization and new product development. We expect sequential and annual growth as the SAS agreement kicks in.
AVTECH services about 6% of the number of aircraft operating globally, and we estimate that about 5% of the market is trialing or scheduled to trial AVTECH’s services. We estimate AVTECH’s pipeline (of an estimated 1,400 aircraft) to be worth SEK27m-43m, with a mid-point of SEK35m. CEO David Rytter stated in his December update that AVTECH has three legacy airlines trialing ClearPath and Aventus. We believe SAS was one of them. Hence, we believe one airline is trialing Aventus and the other ClearPath, with an expected end of the trial in Q1 2024. We expect the remaining two airlines to have a value between SEK1.9m and SEK3.0m, whether for Aventus or ClearPath. We price in about 11% of the pipeline potential to convert by the end of 2024e.
We expect AVTECH to go through an investment phase during 2024, adding support to the organization and investing in new product development. Thus, we do not believe a dividend is on the agenda. We increased our OPEX estimates and reduced our EBITDA estimates between 4.4%-7.3% between Q1 2024 and Q4 2024. We have raised our longer-term forecast. We increased our fair value range from SEK2.9-11.1 with a base case of SEK5.0 to SEK3.5-12.0 with a base case of SEK5.9. The main catalyst remains new airline agreements. The main risk remains Southwest customer concentration.
SEKm | 2021 | 2022 | 2023 | 2024e | 2025e |
Revenues | 16.3 | 25.0 | 32.2 | 38.3 | 46.4 |
Revenue Growth | 4.5% | 53.4% | 28.8% | 18.9% | 21.3% |
EBITDA | 1.5 | 8.9 | 13.4 | 18.5 | 25.7 |
EBIT | -1.6 | 5.2 | 9.1 | 14.9 | 22.1 |
EBIT Margin | -13.6% | 24.5% | 33.1% | 43.0% | 51.5% |
Net Income | -1.6 | 5.2 | 9.1 | 14.9 | 17.4 |
EV/Sales | 10.1 | 7.1 | 7.3 | 6.5 | 4.8 |
EV/EBIT | -74.5 | 29.0 | 22.0 | 15.1 | 9.4 |
Net Sales came in at SEK7.6m, 33%y/y, in line with our estimated SEK7.6m (deviation 0%). New contracts primarily drove sales growth as USDSEK decreased by 1% q/q, based on our estimate. EBITDA came in at SEK3.6m, corresponding to an EBITDA margin of 47% (EBITDA SEK2.7m, EBITDA-margin 47% last year). This is below our estimate of SEK4.1 (deviation -13%). OPEX was above our expectations and deviated by 22%. The main reason for the deviation is increased personnel costs related to new employment and less vacation time during the period.
The USDSEK tailwind has turned into a headwind during the last quarter of the year, decreasing by 1% on average.
AVTECH expects a prototype version of its Dashboard to be ready for customers to use in the first quarter. The Dashboard will allow each customer to monitor each flight’s overall statistics and outcomes independently. This transparency enhances credibility and streamlines the work for AVTECH’s team during testing periods, as customers can now track the results from day one themselves.
AVTECH expects the first version of the Flight Speed Optimizer for ClearPath to be ready for customer trial at the end of Q1 2024, which it expects customers to trial in Q2 2024. Flight Speed Optimizer aims to continuously manage the flight speed to optimize the fuel efficiency of the aircraft. Today, the aircraft’s speed continuously varies during flight, controlled by the flight computer. The computer calculates an optimal airspeed at each point based on the airline’s priorities (time/fuel), current weather conditions, and the aircraft’s weight. The flight computer’s limited weather input and capacity sometimes lead to suboptimal speed profiles. AVTECH’s flight speed optimizer identifies the optimal speeds in each flight segment, providing pilots with a simple tool to optimize them. The result is fuel and time savings, which vary from flight to flight. Additionally, the optimization appears to result in the aircraft flying at a more consistent speed.
In his CEO letter, David Rytter stated that AVTECH invests to maintain high sales and promote future growth. The company welcomed an interim sales manager with over 25 years of expertise and allocated SEK2.0m to expand its product portfolio into areas with synergistic potential. Areas under consideration include enhancing support for airline ground staff and air traffic control to optimize airport traffic flow. AVTECH is exploring partnerships and co-financed research with various entities beyond airlines to support these initiatives.
AVTECH had good momentum with customer intake, signing one agreement in Q4 2023 with Wizz Air UK and one after the quarter ended with SAS. We estimate the total contract intake is worth SEK3.4m annually at the mid-point.
AVTECH signed an agreement with Wizz Air UK, a low-cost carrier operating from the UK and a subsidiary of Hungarian-based Wizz Air. The deal is for Aventus and SIGMA in-flight services, has a three-year duration, and is worth SEK1.1m—1.6m, depending on the EUR/SEK exchange rate.
We estimate the agreement is worth SEK0.5m annually at the midpoint. The contract only covers Wizz Air’s UK operations, with only 18 aircraft operating. Using this figure, we estimate AVTECH earns SEK0.025m per aircraft annually, in line with other agreements. The entire Wizz Air group has 187 aircraft operating. Thus, we estimate the upsell potential for this specific service to be worth cSEK5m annually at the midpoint over time.
AVTECH announced after Q4 2023 ended that it has signed a two-year agreement for ClearPath with SAS with an expected value of SEK5.0m-6.5m, dependent on the number of SAS group aircraft and flights operating with the service. According to Planespotters, SAS has about 90 aircraft operating. We estimate the contract is worth SEK2.5m-3.3m annually, with a mid-point of SEK2.9m.
AVTECH has stated that it has deployed its services on the first batch of aircraft for SAS and that commissioning on future aircraft types is underway. We are unsure about the timeline for the batches, which adds short-term uncertainty to our estimates.
Key contracts and estimated expiration dates can be seen in the table below.
The contract with Southwest, the primary customer, does not expire until 2026-06. Hence, we believe there are limited downside risks to AVTECH’s estimates over the next two years, absent a significant event affecting the entire airline industry, such as a pandemic. However, AVTECH has a significant USDSEK exposure, a known unknown risk.
Before the last two agreements, AVTECH stated it had about 1,500 aircraft trialing or scheduled to trial its services. We did not get an updated number of aircraft, and we adjusted this figure to 1,400 aircraft after the agreements. However, we expect the pipeline to grow continuously.
We estimate AVTECH’s pipeline (of 1,400 aircraft) to be worth SEK27m-43m, with a mid-point of SEK35m. The low end assumes Aventus pricing, while the high end assumes ClearPath. Combining the two would value the pipeline at SEK70m.
CEO David Rytter stated in his December update that AVTECH has three legacy airlines trialing ClearPath and Aventus. We believe SAS was one of them. Hence, we believe one airline is trialing Aventus and the other ClearPath, with an expected end of the trial in Q1 2024. After the trial, we expect one to two-quarters of negotiations. Thus, we are hesitant to expect these in Q1 2024. However, in the same update, CEO David Rytter states AVTECH is working on simplifying the contract process, primarily by reducing the contract length, which he hopes will result in faster customer decision-making.
We expect the remaining two airlines to have a value between SEK1.9m and SEK3.0m, whether for Aventus or ClearPath. AVTECH stated that an unspecified number of airlines will start trialing in January 2024. Below is a timeline of customer acquisition, expected end of trials, and product launches.
We increased our OPEX estimates and reduced our EBITDA estimates between 4.4%-7.3% between Q1 2024 and Q4 2024. Our next twelve-month estimates are as follows:
We increase our 2026e-2028e net sales growth by between 0-5% based on the current pipeline and the potential to upsell Southwest on ClearPath. We estimate Southwest expanding with ClearPath could add about SEK24m in revenue and the same amount to EBIT immediately. Our bull case assumes Southwest will expand its current agreement to include ClearPath in 2026e.
We believe there is a significant upside risk to our estimates, considering we only price in about 11% of the pipeline potential while barely considering Southwest could upgrade to include ClearPath.
During 2023, AVTECH signed four agreements, one of which was an extension of Southwest, which we estimate to be worth SEK15m annually at the mid-point. The new Southwest agreement added SEK2m in incremental sales versus the old agreement (at the midpoint). Excluding Southwest, we estimate these added about SEK4.9m in annual sales. Including only the incremental sales from Southwest, these contracts added SEK6.9m in annual sales.
Our 2024 incremental sales estimate, excluding the SEK2.9m we expect annually from SAS, is SEK3.9m. Considering how the pipeline looks, we find this fair-to-conservative and believe there are significant upsides to our estimates given a larger-than-expected conversion.
We increased our fair value range from SEK2.9-11.1 with a base case of SEK5.0 to SEK3.5-12.0 with a base case of SEK5.9. The main catalyst remains new airline agreements. The main risk remains Southwest customer concentration.
AVTECH trades at a premium on all relevant metrics except EV/EBIT 2025e. We believe this is fair considering the proven earnings power of the business and the pipeline potential.
Based on AVTECH’s operational performance since the pandemic, we have increased our financials rating from 3 to 4. Consequently, we have reduced our discount rate from 11% to 10%.
Our updated base case implies an EV/EBIT on 2024e of 20.8x, about a 20% premium of AVTECH’s two-year EV/EBIT NTM average of 16.5x. The NTM EV/EBIT multiple is 14.5x, below its historic average. Considering the business stability and improved growth prospects, we believe AVTECH should trade in line or at a premium to its historical valuation. We expect customer agreements to catalyze the share.
Case
Mispriced growth potential with short-term catalyst
Evidence
Estimated 1.400 aircraft schedueld to trial
Challenge
Airlines are slower than airplanes
Challenge
Heavy USD exposure
Valuation
Re-rate to factor in growth potential
People: 3
The current leadership has substantial experience in developing systems as well as core competencies in the aviation industry. Over the years, the Company has taken several steps during harsh times that we consider the right action. Although, historically, management has not delivered on its estimates, which is the consequence of a stagnant industry. A lack of focus has previously been a problem for the Company, this has been improved upon as of late, with the focus being Aventus and ClearPath.
Ownership of the Company is aligned with a few larger shareholders who have been operationally active in the Company for several years. These people will add value in the future given their experience and persistence. However, we think an institution and some board re-alignments would be healthy for the growth phase the Company is now transitioning to.
Business: 4
AVTECH has an attractive business model and operates in an attractive niche - highly profitable while to small for large entrants. The difficulty relating to successful procurement processes in the sector lies within the fact that many companies prioritize other efficiency measures first, and the bureaucratic organization for legacy carriers does not benefit AVTECH.
Financials: 4
AVTECH has gone through a tough period with the pandemic. However, the Company has successfully controlled its costs and are on a solid groud post-pandemic. With the latest Southwest contract (announced 2022-01-17) the Company has shown solid and growing profitability. The main reason the Company did not earn a higher rating on finanicals is the lack of historic profitability. We expect to increase the score once AVTECH has kept the current financial profile over a ten year period.
Income statement | |||||
SEKm | 2021 | 2022 | 2023e | 2024e | 2025e |
Revenues | 16.3 | 25.0 | 31.0 | 38.3 | 46.4 |
Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 17.9 | 19.8 | 22.6 | 23.4 | 24.4 |
EBITDA | 1.5 | 8.9 | 12.7 | 18.5 | 25.7 |
Depreciation | -0.02 | 0.00 | 0.01 | 0.01 | 0.01 |
Amortizations | 3.1 | 3.7 | 3.6 | 3.6 | 3.6 |
EBIT | -1.6 | 5.2 | 8.4 | 14.9 | 22.0 |
Shares in Associates | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Financial Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EBT | -1.6 | 5.2 | 8.4 | 14.9 | 22.0 |
Income Tax Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 4.6 |
Net Income | -1.6 | 5.2 | 8.4 | 14.9 | 17.4 |
Balance sheet | |||||
Assets | |||||
Non-current assets | |||||
SEKm | 2021 | 2022 | 2023e | 2024e | 2025e |
Property, Plant and Equipment (Net) | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intangible Assets | 13.7 | 13.8 | 13.8 | 13.8 | 13.8 |
Right-of-Use Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non-Current Assets | 0.39 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Non-Current Assets | 14.3 | 13.8 | 13.8 | 13.8 | 13.8 |
Current assets | |||||
SEKm | 2021 | 2022 | 2023e | 2024e | 2025e |
Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Receivable | 2.1 | 0.00 | 6.8 | 8.6 | 10.6 |
Other Current Assets | 1.4 | 5.3 | 0.55 | 0.69 | 0.86 |
Cash Equivalents | 10.2 | 14.6 | 24.8 | 39.4 | 56.5 |
Total Current Assets | 13.7 | 19.9 | 32.1 | 48.7 | 67.9 |
Total Assets | 27.9 | 33.7 | 45.9 | 62.5 | 81.7 |
Equity and Liabilities | |||||
Equity | |||||
SEKm | 2021 | 2022 | 2023e | 2024e | 2025e |
Non Controlling Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Shareholder's Equity | 25.1 | 31.2 | 38.7 | 53.6 | 71.0 |
Non-current liabilities | |||||
SEKm | 2021 | 2022 | 2023e | 2024e | 2025e |
Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Long Term Lease Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Long Term Liabilities | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Non-Current Liabilities | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 |
Current liabilities | |||||
SEKm | 2021 | 2022 | 2023e | 2024e | 2025e |
Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Short Term Lease Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable | 0.79 | 0.00 | 3.0 | 3.8 | 4.7 |
Other Current Liabilities | 0.33 | 2.5 | 3.3 | 4.2 | 5.1 |
Total Current Liabilities | 2.8 | 2.5 | 6.3 | 8.0 | 9.9 |
Total Liabilities and Equity | 27.9 | 33.7 | 45.9 | 62.5 | 81.7 |
Cash flow | |||||
SEKm | 2021 | 2022 | 2023e | 2024e | 2025e |
Operating Cash Flow | -1.9 | 6.8 | 13.8 | 18.2 | 20.7 |
Investing Cash Flow | 0.00 | -3.7 | -3.6 | -3.6 | -3.6 |
Financing Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Disclosures and disclaimers
Contents
Estimates vs outcome
Several product launches are expected during 2024
Solid customer intake paves the way for sequential growth
Wizz Air
SAS – After quarter end
The pipeline is estimated to be worth SEK27m-43m
Lower EBITDA during the investment phase but higher longer-term
Trades below historic NTM EV/EBIT
Investment thesis
Quality Rating
Financials
Rating definitions
The team
Download article